OCULAR THERAPEUTIX, INC — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/623def81-418f-43d5-a312-669b71fc64fe/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $52.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-010664 |
| FY 2024 | $63.7M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002000 |
| FY 2023 | $58.4M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002902 |
| FY 2022 | $51.5M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002908 |
| FY 2021 | $43.5M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002363 |
| FY 2020 | $17.4M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002813 |
| FY 2019 | $4.2M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002537 |
| FY 2018 | $2.0M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002537 |
| FY 2017 | $1.9M | 2017-01-01 – 2017-12-31 | evidence 0001558370-20-002537 |
| FY 2016 | $1.9M | 2016-01-01 – 2016-12-31 | evidence 0001558370-19-001659 |
| FY 2015 | $1.8M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-499184 |
| FY 2014 | $772.0k | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-099288 |
| FY 2012 | $10.0k | 2012-01-01 – 2012-12-31 | evidence 0001193125-15-099288 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
OCULAR THERAPEUTIX, INC — all facts · Net Income · Operating Income